Recursos del Paciente
Manténgase sano!
Resultados de su búsqueda "Cancer: Bladder".
Resultados de noticias de salud - 14
Post-Op Keytruda Boosts Bladder Cancer Outcomes
- September 18, 2024
- Página completa
When given after organ-removal surgery, Keytruda brings patients battling advanced bladder cancers more time cancer-free, a new trial finds.
Folks with "high-risk" bladder cancers -- tumors that had already invaded nearby...
King Charles Returns to Duties After Cancer Treatment
- Ernie Mundell HealthDay Reporter
- April 29, 2024
- Página completa
Britain's King Charles III is back to resuming his royal duties following treatment for cancer, Buckingham Palace announced Friday.
"His Majesty The King will shortly return to public-facing duties after a period of treatment and recuperation following his recent cancer...
Urine Test Could Cut Need for Painful Bladder Cancer Procedure
- Dennis Thompson HealthDay Reporter
- April 8, 2024
- Página completa
A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report.
People who've gotten surgery for high-risk bladder cancer require a cystoscopy -- a procedure in which a flexible ...
Drug Combo Marks Advance Against Bladder Cancer
- Ernie Mundell HealthDay Reporter
- March 11, 2024
- Página completa
A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.
Patients who took a combo of meds called EV+P -- enfortumab vedotin and pembrolizumab (Keytruda) -- had an average 31.5 months surviva...
Treatment Strategy Helps People With Advanced Bladder Cancer Retain the Organ
- Alan Mozes HealthDay Reporter
- October 10, 2023
- Página completa
"Listen, I'm not a Pollyanna,"New Yorker David Cabelis makes clear. "I'm a cab driver."
"But I was diagnosed with this cancer,"the 72-year old said. "Bladder cancer, that's what I had, and then I had this treatment, and it was the most amazing experience. And thank God, ...
Could Loss of the Y Chromosome Help Speed Cancers in Men?
- Dennis Thompson HealthDay Reporter
- June 21, 2023
- Página completa
It's common knowledge that loss is a part of male aging -- loss of hair, loss of muscle tone, loss of vision or hearing.
But men growing older also start losing the very thing that makes them biological males, their Y chromosome, and that can leave them more vulnerable t...
Patients With Bladder Cancer May Avoid Removal of Extra Lymph Nodes, Study Finds
- Amy Norton HealthDay Reporter
- June 7, 2023
- Página completa
For years, doctors have thought that a more extensive surgery that removes a wider swath of lymph nodes was the best option for certain patients with bladder cancer. Now, a new clinical trial is upending that belief.
Researchers found that the strategy -- known as exten...
FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer
- Cara Murez HealthDay Reporter
- December 19, 2022
- Página completa
Patients with a high-risk bladder cancer now have a new option to treat it.
The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have what's called high-risk non-muscle-invasive bladder can...
U.S. Cancer Death Rates Continue to Decline
- Ernie Mundell HealthDay Reporter
- October 27, 2022
- Página completa
The latest statistics from the U.S. National Cancer Institute (NCI) show a continuing decline in the number of Americans who die from cancer, although there's been little change in the number of new cancer cases.
"From 2015 to 2019, overall cancer death rates decreased b...
Football Great Terry Bradshaw Describes Battle Against Two Kinds of Cancer
- By Cara Murez and Robin Foster HealthDay Reporters
- October 4, 2022
- Página completa
Football Hall of Famer Terry Bradshaw revealed Sunday that he has been treated for two different types of cancer in the past year.
Immunotherapy Drug Can Lower Recurrence When Bladder Cancer Spreads
- Steven Reinberg HealthDay Reporter
- May 16, 2022
- Página completa
Immunotherapy with nivolumab (Opdivo) after surgery for metastatic bladder cancer significantly reduces the odds for the tumor's return, a new clinical trial finds.
Missed Cancer Screenings During Pandemic Could Raise Death Rate for Years
- March 21, 2022
- Página completa
The early months of the COVID-19 pandemic kept millions of Americans away from routine cancer screenings. Now a new study finds that many U.S. screening programs were still not back to normal by 2021.
The study, of more than 700 cancer facilities nationwide, found that i...
More Evidence That Pandemic Delayed Cancer Diagnoses
- Robert Preidt
- December 6, 2021
- Página completa
New research offers fresh proof that the COVID-19 pandemic delayed cancer diagnoses in the United States, increasing patients' risk for poor outcomes.
For the study, researchers analyzed data from more than 9 million patients at over 1,200 Veterans Affairs (VA) medical f...
Cancer Care Costs U.S. $156 Billion Per Year; Drugs a Major Factor
- Robert Preidt
- October 13, 2021
- Página completa
Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.
Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State C...